Physician profile
Troy S Wilde
NPI 1023306933
$6,557.80
in general payments reported to CMS, 2019-2025
12 companies · $27.45 in 2025
The $27.45 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,308 · 2020: $158 · 2021: $1,710 · 2022: $228 · 2023: $95.33 · 2024: $30.40 · 2025: $27.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $3,589.49 | 2019-2021 | |
| Bone Support INC. | $1,619.72 | 2020-2021 | |
| Kci USA, INC. | $666.85 | 2019-2021 | |
| Anika Therapeutics, INC. | $276.38 | 2021-2022 | |
| Smith+Nephew, INC. | $144.59 | 2019-2025 | Oasis, Grafix Pl |
| Abbvie INC. | $87.34 | 2022-2023 | Dalvance |
| Derma Sciences, INC. | $65.79 | 2019 | |
| Horizon Therapeutics Plc | $37.94 | 2019 | |
| Mimedx Group, INC. | $30.40 | 2024 | |
| Next Science LLC | $18.19 | 2022 | |
| Tei Medical INC. | $10.82 | 2019 | |
| Terumo Bct, INC. | $10.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Wilde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.